OVIDE NEWS HIGHLIGHTS
Media Articles Related to Ovide (Malathion Topical)
Lipitor 80 Mg Provided Sustained Risk Reduction Of Cardiovascular Events In Patients With Heart Disease During The Five-Year TNT Trial Source: Cardiovascular / Cardiology News From Medical News Today [2008.09.03]
Business Week Examines Practice Of Balance Billing By Medical Providers Source: Health Insurance / Medical Insurance News From Medical News Today [2008.09.03]
Whistle-Blower Lawsuits Helped Recover At Least $9.3B From Health Care Providers Accused Of Defrauding States, Federal Government, Analysis Finds Source: Pharma Industry / Biotech Industry News From Medical News Today [2008.09.03]
OptumHealth Provides Free Counseling Help Line For People Coping With Tropical Storm Gustav Source: Aid / Disasters News From Medical News Today [2008.09.01]
Are You At Risk For Gum Disease? CIGNA Dental's New Online Tool Helps Provide The Answer Source: Dentistry News From Medical News Today [2008.09.01]
Published Studies Related to Ovide (Malathion Topical)
Efficacy of a reduced application time of Ovide lotion (0.5% malathion) compared to Nix creme rinse (1% permethrin) for the treatment of head lice. [2004.11]
A randomized, investigator-blinded, time-ranging study of the comparative efficacy of 0.5% malathion gel versus Ovide Lotion (0.5% malathion) or Nix Creme Rinse (1% permethrin) used as labeled, for the treatment of head lice. [2007.07]
Survey of permethrin and malathion resistance in human head lice populations from Denmark. [2006.05]
Decreasing malathion application time for lice treatment reduces transdermal absorption. [2005.09.14]
Effects of local blood flow on the percutaneous absorption of the organophosphorus compound malathion: a microdialysis study in man. [2001.08]
Clinical Trials Related to Ovide (Malathion Topical)
Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice [Completed]
Safety and Tolerability of a Novel Malathion Formulation in Infants and Toddlers With Head Lice [Terminated]
Does Quality of Life Improve in Multiple Sclerosis Patients Treated With Interferon Beta-1a? [Completed]
Abciximab in Wake-up Stroke [Terminated]
|